Are Immature Platelets Growing Up?: Toward a New Marker of Antiplatelet Drug Resistance

Journal of the American College of Cardiology

Volumn 68, Issue 3, 2016, Pages 294-296

  Kleiman, Neal S ^a,b  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

clopidogrel; percutaneous coronary intervention; prasugrel; reticulated platelets

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PRASUGREL; TICAGRELOR; ANTITHROMBOCYTIC AGENT; TICLOPIDINE;

BLOOD CLOTTING PARAMETERS; CELL MATURATION; CORONARY ARTERY DISEASE; EDITORIAL; ERYTHROCYTE; FLOW CYTOMETRY; HEART INFARCTION; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; RETICULOCYTE; STENT THROMBOSIS; THROMBOCYTE; THROMBOCYTE COUNT; ACUTE CORONARY SYNDROME;

ACUTE CORONARY SYNDROME; BLOOD PLATELETS; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PRASUGREL HYDROCHLORIDE; TICLOPIDINE;

EID: 84979942223     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.04.055     Document Type: Editorial

References (19)

1. 1 Gurbel, P.A., Bliden, K.P., Hiatt, B.L., O'Connor, C.M., Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity. Circulation 107 (2003), 2908–2913.
2. 2 Stone, G.W., Witzenbichler, B., Weisz, G., et al. Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study. Lancet 382 (2013), 614–623.
3. 3 Price, M.J., Berger, P.B., Teirstein, P.S., et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention. JAMA 305 (2011), 1097–1105.
4. 4 Collet, J.P., Cuisset, T., Range, G., et al. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367 (2012), 2100–2109.
5. 5 Trenk, D., Stone, G.W., Gawaz, M., et al. A Randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study. J Am Coll Cardiol 59 (2012), 2159–2164.
6. 6 Wang, T.Y., Henry, T.D., McCoy, L.A., et al. Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United States. Am Heart J 170 (2015), 706–714.
7. 7 Shuldiner, A.R., O'Connell, J.R., Bliden, K.P., et al. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA 302 (2009), 849–857.
8. 8 Stratz, C., Bömicke, T., Younas, I., et al. Comparison of immature platelet count to established predictors of platelet reactivity during thienopyridine therapy. J Am Coll Cardiol 68 (2016), 286–293.
9. 9 Karpatkin, S., Heterogeneity of human platelets. II. Functional evidence suggestive of young and old platelets. J Clin Invest 48 (1969), 1083–1087.
10. 10 Lee, L.G., Chen, C.H., Chiu, L.A., Thiazole orange: a new dye for reticulocyte analysis. Cytometry 7 (1986), 508–517.
11. 11 Kienast, J., Schmitz, G., Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75 (1990), 116–121.
12. 12 Ault, K.A., Knowles, C., In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 23 (1995), 996–1001.
13. 13 Rowley, J.W., Schwertz, H., Weyrich, A.S., Platelet mRNA: the meaning behind the message. Curr Opin Hematol 19 (2012), 385–391.
14. 14 Ibrahim, H., Nadipalli, S., Usmani, S., et al. Detection and quantification of circulating immature platelets: agreement between flow cytometric and automated detection. J Thromb Thrombolysis 42 (2016), 77–83.
15. 15 Guthikonda, S., Lev, E.I., Patel, R., et al. Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 5 (2007), 490–496.
16. 16 Guthikonda, S., Alviar, C.L., Vaduganathan, M., et al. Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52 (2008), 743–749.
17. 17 Ibrahim, H., Nadipalli, S., DeLao, T., Guthikonda, S., Kleiman, N.S., Immature platelet fraction (IPF) determined with an automated method predicts clopidogrel hyporesponsiveness. J Thromb Thrombolysis 33 (2012), 137–142.
18. 18 Ibrahim, H., Schutt, R.C., Hannawi, B., DeLao, T., Barker, C.M., Kleiman, N.S., Association of immature platelets with adverse cardiovascular outcomes. J Am Coll Cardiol 64 (2014), 2122–2129.
19. 19 Hochholzer, W., Amann, M., Titov, A., et al. Randomized comparison of different thienopyridine loading strategies in patients undergoing elective coronary intervention: the ExcelsiorLOAD trial. J Am Coll Cardiol Intv 9 (2016), 219–227.